highly significantP < .001
The treatment group demonstrated a highly significant reduction in PII ( P < .001), BOP ( P < .005), PPD ( P < 0.001), and CAL ( P < .001) at reassessment following phase 1 periodontal therapy ( Table 2 ).
The treatment group demonstrated a highly significant reduction in PII ( P < .001), BOP ( P < .005), PPD ( P < 0.001), and CAL ( P < .001) at reassessment following phase 1 periodontal therapy ( Table 2 ).